Exelixis
EXEL
#1639
Rank
NZ$17.87 B
Marketcap
$63.86
Share price
-0.35%
Change (1 day)
70.66%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company